Clinical Trials Browser

Phase 3 × Recruiting × Antineoplastic Agents × Clear all

NCT05566795 2026-03-02

DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)

Phase 3 Recruiting

Noonan Syndrome 5